Kalkofen Donald A. 4
4 · Protagonist Therapeutics, Inc · Filed Jun 3, 2019
Insider Transaction Report
Form 4
Kalkofen Donald A.
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2019-05-31+100,000→ 100,000 totalExercise: $10.06Exp: 2029-05-30→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]This option vests over a four-year period with 25% of the shares underlying the option vesting on the one-year anniversary of the vesting commencement date of May 28, 2019, and the balance vesting in equal monthly installments over the following 36 months.